Milind Thatte is Merck's New MD
Drug firm Merck Ltd. has announced that Mr. Milind Thatte has been appointed as Managing Director of the company effective from April 1, 2018. The company’s board appointed Mr. Thatte, General Manager Healthcare, as an Additional Director and Managing Director of the company, in place of Mr. Anand Nambiar, Merck informed in a stock exchange filing. Earlier Mr. Thatte headed the healthcare business of India and frontier markets. He heads the leadership team of healthcare sector and is the member of the country council of Merck India, the company informed.
You May Interested In
Glow70/KLOW80 99% China Peptides Warehouse Direct Delivery Lyophilized Powder in Stock
$169/UNIT FOB
2026-10-15
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Merck Wins Approval for the World’s First Oral PCSK9 Drug, with Potential Annual Sales of $5 Billion
-
Merck Establishes New Semiconductor Hub in Taiwan
-
Merck Completes Sale of Surface Solutions Business to GNMI for €665 Million
-
Merck and Siemens Collaborate on Smart Manufacturing
-
Merck sells Surface Solutions to Global New Material International for €665 million in cash
-
Merck Group acquires chip equipment supplier Unity-SC for €155 million
-
Merck Launches Commercial Production of First GMP-Compliant Cell Culture Media Production Line in China
-
Merck to acquire EyeBio for $3 billion
-
Circa signs OEM agreement with Merck to supply and sell Cyrene
-
The Rising Heat of DAC Drugs: ADC and PROTAC Sparking Innovation
Recommend Reading
-
![Overseas Up, China Down: The Global MDI Market Is Splitting Apart]()
Overseas Up, China Down: The Global MDI Market Is Splitting Apart
-
![Yulong Petrochemical’s 100,000-ton MMA Project Comes Online Amid a “Deep V-Shaped Rebound” — Opportunity or Hidden Risk?]()
Yulong Petrochemical’s 100,000-ton MMA Project Comes Online Amid a “Deep V-Shaped Rebound” — Opportunity or Hidden Risk?
-
![BASF Battles Market Turmoil as Profits Slide]()
BASF Battles Market Turmoil as Profits Slide
-
![Covestro Unveils TPU Application Development Hub in Guangzhou, Strengthening Regional Innovation Network]()
Covestro Unveils TPU Application Development Hub in Guangzhou, Strengthening Regional Innovation Network
-
![McKinsey Pays to Close a Purdue Liability Chapter]()
McKinsey Pays to Close a Purdue Liability Chapter
-
![Recent Continuous Decline in the Ethyl Acetate Market in China]()
Recent Continuous Decline in the Ethyl Acetate Market in China
-
![HNO2 (Nitrous Acid): Properties, Uses, and Safety]()
HNO2 (Nitrous Acid): Properties, Uses, and Safety
-
![Returning to Fundamentals: Ethylene Glycol Prices in April Show Volatile and Weak Trends]()
Returning to Fundamentals: Ethylene Glycol Prices in April Show Volatile and Weak Trends
-
![Both Cost and Demand Weighing Down PTA Prices, Leading to Volatile Declines]()
Both Cost and Demand Weighing Down PTA Prices, Leading to Volatile Declines
-
![Both Costs and Consumption Weak, ABS Continues to Decline]()
Both Costs and Consumption Weak, ABS Continues to Decline
- Hot Searches
- phenol price
- best place to buy retatrutide peptides
- retatrutide 30mg for sale
- where can you buy formaldehyde
- how much does kerosene cost a gallon
- ammonium sulphate crystalline
- retatrutide buy online usa
- methylamine price per gallon
- k2o potassium oxide
- teriparatide injection
- dipotassium phosphate distributor
- where can i get retatrutide